Birdwatch Note
2024-09-19 09:02:06 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
不良という意味が不明瞭ですが、投稿者は香港の不活化ワクチンの話を好評価の根拠としてあげているのでそのエビデンスを挙げます。 https://x.com/BB45_Colorado/status/1740407811375550709 ファイザーワクチンと不活化ワクチンcoronavac(1)の接種後の特に注意する有害事象の医療記録を比較すると、死亡率は差がみられず、アナフィラキシーや睡眠障害、心筋炎は前者が多い一方、後者はベル麻痺が有意に多く、全体的な有害事象は有意差が見られずという結果でした(2,3)。 (1) https://medical.nikkeibp.co.jp/leaf/mem/pub/report/t344/202108/571415.html (2) https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004018 (3) https://www.sciencedirect.com/science/article/pii/S1201971224002200 有効性に関しては同じく直接比較を行うとオミクロンに対してファイザーワクチンの方が大きく上回っています。 https://www.sciencedirect.com/science/article/pii/S1201971224002200
Written by 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1836617264352895381
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1836692229664149752
- noteId - 1836692229664149752
- participantId -
- noteAuthorParticipantId - 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE Participant Details
- createdAtMillis - 1726736526300
- tweetId - 1836617264352895381
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 不良という意味が不明瞭ですが、投稿者は香港の不活化ワクチンの話を好評価の根拠としてあげているのでそのエビデンスを挙げます。 https://x.com/BB45_Colorado/status/1740407811375550709 ファイザーワクチンと不活化ワクチンcoronavac(1)の接種後の特に注意する有害事象の医療記録を比較すると、死亡率は差がみられず、アナフィラキシーや睡眠障害、心筋炎は前者が多い一方、後者はベル麻痺が有意に多く、全体的な有害事象は有意差が見られずという結果でした(2,3)。 (1) https://medical.nikkeibp.co.jp/leaf/mem/pub/report/t344/202108/571415.html (2) https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004018 (3) https://www.sciencedirect.com/science/article/pii/S1201971224002200 有効性に関しては同じく直接比較を行うとオミクロンに対してファイザーワクチンの方が大きく上回っています。 https://www.sciencedirect.com/science/article/pii/S1201971224002200
Note Ratings
rated at | rated by | |
2024-09-30 03:09:05 -0500 | Rating Details | |
2024-09-30 01:54:35 -0500 | Rating Details | |
2024-09-26 10:03:39 -0500 | Rating Details | |
2024-09-21 06:07:41 -0500 | Rating Details | |
2024-09-20 02:38:01 -0500 | Rating Details | |
2024-09-19 22:56:43 -0500 | Rating Details | |
2024-09-19 21:45:37 -0500 | Rating Details | |
2024-09-19 20:53:30 -0500 | Rating Details | |
2024-09-19 20:38:19 -0500 | Rating Details | |
2024-09-19 19:07:04 -0500 | Rating Details | |
2024-09-19 18:39:35 -0500 | Rating Details | |
2024-09-19 18:26:05 -0500 | Rating Details | |
2024-09-19 16:01:54 -0500 | Rating Details | |
2024-09-19 15:58:29 -0500 | Rating Details | |
2024-09-19 14:48:46 -0500 | Rating Details | |
2024-09-19 14:43:24 -0500 | Rating Details | |
2024-09-19 12:56:25 -0500 | Rating Details | |
2024-09-19 12:27:23 -0500 | Rating Details | |
2024-09-19 12:16:46 -0500 | Rating Details | |
2024-09-19 12:13:51 -0500 | Rating Details | |
2024-09-19 11:19:13 -0500 | Rating Details | |
2024-09-19 10:15:53 -0500 | Rating Details | |
2024-09-19 10:06:04 -0500 | Rating Details | |
2024-09-19 09:53:53 -0500 | Rating Details | |
2024-09-19 09:44:49 -0500 | Rating Details | |
2024-09-19 09:44:33 -0500 | Rating Details | |
2024-09-19 09:42:31 -0500 | Rating Details | |
2024-09-19 09:28:13 -0500 | Rating Details | |
2024-09-19 09:15:46 -0500 | Rating Details | |
2024-09-19 08:34:38 -0500 | Rating Details | |
2024-09-19 08:33:25 -0500 | Rating Details | |
2024-09-19 08:22:05 -0500 | Rating Details | |
2024-09-19 07:49:50 -0500 | Rating Details | |
2024-09-19 07:32:13 -0500 | Rating Details | |
2024-09-19 07:22:28 -0500 | Rating Details | |
2024-09-19 07:21:51 -0500 | Rating Details | |
2024-09-19 07:21:19 -0500 | Rating Details | |
2024-09-19 07:16:58 -0500 | Rating Details | |
2024-09-19 07:09:12 -0500 | Rating Details | |
2024-09-19 06:59:18 -0500 | Rating Details | |
2024-09-19 06:54:29 -0500 | Rating Details | |
2024-09-19 06:41:48 -0500 | Rating Details | |
2024-09-19 06:38:55 -0500 | Rating Details | |
2024-09-19 06:37:45 -0500 | Rating Details | |
2024-09-19 06:21:26 -0500 | Rating Details | |
2024-09-19 06:20:49 -0500 | Rating Details | |
2024-09-19 06:10:28 -0500 | Rating Details | |
2024-09-19 06:04:06 -0500 | Rating Details | |
2024-09-19 05:59:24 -0500 | Rating Details | |
2024-09-19 05:58:50 -0500 | Rating Details | |
2024-09-19 05:52:51 -0500 | Rating Details | |
2024-09-19 05:40:52 -0500 | Rating Details | |
2024-09-19 05:30:48 -0500 | Rating Details | |
2024-09-19 05:16:34 -0500 | Rating Details | |
2024-09-19 05:12:16 -0500 | Rating Details | |
2024-09-19 05:09:45 -0500 | Rating Details | |
2024-09-19 05:01:11 -0500 | Rating Details | |
2024-09-19 04:50:52 -0500 | Rating Details | |
2024-09-19 04:50:21 -0500 | Rating Details | |
2024-09-19 04:48:10 -0500 | Rating Details | |
2024-09-19 04:45:01 -0500 | Rating Details | |
2024-09-19 04:43:41 -0500 | Rating Details | |
2024-09-19 04:39:31 -0500 | Rating Details | |
2024-09-19 04:36:34 -0500 | Rating Details | |
2024-09-19 04:36:09 -0500 | Rating Details | |
2024-09-19 04:34:58 -0500 | Rating Details | |
2024-09-19 04:30:36 -0500 | Rating Details | |
2024-09-19 04:28:36 -0500 | Rating Details | |
2024-09-19 04:28:09 -0500 | Rating Details | |
2024-09-19 04:26:38 -0500 | Rating Details | |
2024-09-19 04:18:56 -0500 | Rating Details | |
2024-09-19 04:09:02 -0500 | Rating Details | |
2024-09-19 04:05:47 -0500 | Rating Details | |
2024-10-02 01:44:06 -0500 | Rating Details | |
2024-10-01 21:42:12 -0500 | Rating Details | |
2024-10-01 20:26:06 -0500 | Rating Details | |
2024-10-01 20:06:11 -0500 | Rating Details | |
2024-10-01 17:49:42 -0500 | Rating Details | |
2024-10-01 17:12:16 -0500 | Rating Details | |
2024-10-01 14:47:55 -0500 | Rating Details | |
2024-10-01 08:47:41 -0500 | Rating Details | |
2024-10-01 07:50:24 -0500 | Rating Details | |
2024-10-01 07:39:32 -0500 | Rating Details | |
2024-10-01 07:38:36 -0500 | Rating Details | |
2024-10-01 07:33:32 -0500 | Rating Details | |
2024-10-01 07:05:35 -0500 | Rating Details | |
2024-10-01 06:41:52 -0500 | Rating Details | |
2024-10-01 06:40:48 -0500 | Rating Details | |
2024-10-01 00:30:35 -0500 | Rating Details | |
2024-09-30 23:40:09 -0500 | Rating Details | |
2024-10-03 22:14:09 -0500 | Rating Details | |
2024-10-03 16:32:25 -0500 | Rating Details | |
2024-10-03 02:53:20 -0500 | Rating Details | |
2024-10-02 20:17:25 -0500 | Rating Details | |
2024-10-02 07:20:51 -0500 | Rating Details | |
2024-10-01 22:25:26 -0500 | Rating Details | |
2024-10-01 09:14:53 -0500 | Rating Details | |
2024-10-01 06:32:08 -0500 | Rating Details | |
2024-10-01 01:59:59 -0500 | Rating Details | |
2024-10-05 10:20:39 -0500 | Rating Details | |
2024-10-03 15:43:18 -0500 | Rating Details | |
2024-10-01 17:44:45 -0500 | Rating Details | |
2024-10-01 07:22:32 -0500 | Rating Details | |
2024-10-03 08:19:08 -0500 | Rating Details | |
2024-10-01 08:33:40 -0500 | Rating Details | |
2024-10-01 07:02:40 -0500 | Rating Details |